Post-approval studies (Phase 4)UnknownNCT05902429
What this trial is testing
Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Pontificia Universidade Católica do Rio Grande do Sul 10